🇬🇧·3h agoRegulatory
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Publisher
M
MHRA UK
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on gov.uk
Leave the platform to read the original full article on the publisher site.
Source: MHRA UK
Scope: Regulatory
Related coverage
More related coverage
EOF Greece·6h ago
Ανάκληση της Άδειας Χονδρικής πώλησης φαρμάκων για Ανθρώπινη Χρήση στο πρατήριο της εταιρείας ΕΝΟΡΑΣΙΣ ΑΕ
EOF Greece·7h ago
Ανάκληση των παρτίδων 17270129, 17363725, 17385132, του φαρμακευτικού προϊόντος VISIPAQUE INJ.SOL 625 MG(320MG I)/ML BTx1 USB BOTTLE x 100ml
EOF Greece·7h ago
Έντυπα & Διαδικασίες Τμήματος Τιμολόγησης
Certara·2h ago